1,2-dimethylhydrazine has been researched along with Compensatory Hyperinsulinemia in 1 studies
1,2-Dimethylhydrazine: A DNA alkylating agent that has been shown to be a potent carcinogen and is widely used to induce colon tumors in experimental animals.
1,2-dimethylhydrazine : A member of the class of hydrazines that is hydrazine in which one of the hydrogens attached to each nitrogen is replaced by a methyl group. A powerful DNA alkylating agent and carcinogen, it is used to induce colon cancer in laboratory rats and mice.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, TC | 1 |
| Briviba, K | 1 |
| Watzl, B | 1 |
| Bub, A | 1 |
| Barth, SW | 1 |
1 other study available for 1,2-dimethylhydrazine and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Obesity-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemia rather than hyperinsulinemia.
Topics: 1,2-Dimethylhydrazine; Animals; Caloric Restriction; Cell Division; Colonic Neoplasms; Comet Assay; | 2008 |